Cancer Research Career Enhancement and Related Activities With education as the fourth pillar of its overall mission to End Cancer, The University of Texas MD Anderson Cancer Center is an accredited, degree-granting institution with numerous efforts in education, training, and career development across the spectrum of cancer research and translation, the science of cancer prevention, and clinical practice. More than 1,700 faculty and 7,000 annually appointed trainees?from high school through research postdoctoral fellows and clinical residents, as well as a community of lifelong learners among our research and administrative staff?take part in a wide array of offerings sponsored by multiple educational stakeholders from across the institution. Our long-term objective is to establish MD Anderson as a model for education and training in cancer research for a diverse, multidisciplinary research workforce through dissemination of best practices and organization of innovative, evidence-based curricula designed for 21st- century team-based science and clinical practice. Overall, the uniquely broad and rich environment for clinical and research education and professional development at MD Anderson demands easy access to high-quality resources for its learners, as individuals and as groups; for instructors to develop useful and effective activities in synergy; and for support and evaluation of such programs. With this in mind, our 5-year goals include multiple innovative efforts across all CCSG programs in 4 emphasis areas: 1) recruitment coordinated among stakeholders with new approaches that emphasize inclusiveness of underrepresented research trainees and those with disabilities; 2) facilitating access to research education via improved alignment and increased impact; 3) support applications centralized for access by all programs; and 4) program evaluation services tailored for support and improvement of current and developing efforts to improve mentorship and career development. To achieve our long-term objectives for the MD Anderson Cancer Research Career Enhancement and Related Activities (CRCE), our continuous efforts and coordinating role across the institution in education and training are described by these overall aims:
Aim 1 : To recruit, train, and promote a demographically diverse pool of research scientists who span all stages of training and faculty appointment using multiple rigorous strategies to reach broad audiences;
Aim 2 : To provide innovative and evidence-based educational and professional development opportunities in a nurturing culture of shared learning that is attuned to the needs of trainees and faculty mentors;
and Aim 3 : To serve as a coordination and support hub for innovation in education/training, sharing best practices, monitoring research training needs, and program evaluation for MD Anderson researchers, including the community of training programs at MD Anderson.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016672-43
Application #
9794670
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
43
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Knijnenburg, Theo A; Wang, Linghua; Zimmermann, Michael T et al. (2018) Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep 23:239-254.e6
Gao, Qingsong; Liang, Wen-Wei; Foltz, Steven M et al. (2018) Driver Fusions and Their Implications in the Development and Treatment of Human Cancers. Cell Rep 23:227-238.e3
Ikeda, Sadakatsu; Lim, Jordan S; Kurzrock, Razelle (2018) Analysis of Tissue and Circulating Tumor DNA by Next-Generation Sequencing of Hepatocellular Carcinoma: Implications for Targeted Therapeutics. Mol Cancer Ther 17:1114-1122
Ferrarotto, Renata; Cardnell, Robert; Su, Shirley et al. (2018) Poly ADP-ribose polymerase-1 as a potential therapeutic target in Merkel cell carcinoma. Head Neck 40:1676-1684
Sammour, Tarik; Malakorn, Songphol; Bednarski, Brian K et al. (2018) Oncological Outcomes After Robotic Proctectomy for Rectal Cancer: Analysis of a Prospective Database. Ann Surg 267:521-526
Burger, Jan A; Wiestner, Adrian (2018) Targeting B cell receptor signalling in cancer: preclinical and clinical advances. Nat Rev Cancer 18:148-167
Hobbs, Brian P; Chen, Nan; Lee, J Jack (2018) Controlled multi-arm platform design using predictive probability. Stat Methods Med Res 27:65-78
Gadhikar, Mayur A; Zhang, Jiexin; Shen, Li et al. (2018) CDKN2A/p16 Deletion in Head and Neck Cancer Cells Is Associated with CDK2 Activation, Replication Stress, and Vulnerability to CHK1 Inhibition. Cancer Res 78:781-797
Vial, Macarena R; O'Connell, Oisin J; Grosu, Horiana B et al. (2018) Diagnostic performance of endobronchial ultrasound-guided mediastinal lymph node sampling in early stage non-small cell lung cancer: A prospective study. Respirology 23:76-81
Housten, Ashley J; Lowenstein, Lisa M; Leal, Viola B et al. (2018) Responsiveness of a Brief Measure of Lung Cancer Screening Knowledge. J Cancer Educ 33:842-846

Showing the most recent 10 out of 12418 publications